But is UnitedHealth Group stock instead a brilliant bad news buy? One thing after another UnitedHealth Group's challenges ...

UnitedHealth Group faces short-term challenges, but strong fundamentals, undervaluation, and long-term growth potential make ...

Due to the sharp price decline, the yield from the stock's dividend has climbed to 2.8%, which is higher than the S&P 500 ...

May 13 (UPI) -- UnitedHealth Group announced Tuesday CEO Andrew Witty will step down, citing "personal reasons." Witty will leave the role of CEO and be replaced by Stephen J. Hemsley, effective ...

The health care conglomerate is facing mounting financial problems – and ongoing consumer anger over high costs and denied ...

Witty, who largely led the U.S. healthcare giant from the U.K., made big bets on Medicare enrollees that backfired.

Andrew Witty’s departure as CEO is due to "personal reasons," UnitedHealth Group announced on May 13. The company tapped Stephen J. Hemsley, who served as its CEO from 2006 to 2017, to replace ...

Andrew Witty is stepping down from his position as UnitedHealth's CEO for personal reasons, insurer says in surprise announcement.

A significant influence on a stock price, at least over the short term, is how a company's quarterly earnings are perceived.

UnitedHealth Group is being investigated for possible Medicare fraud, according to The Wall Street Journal, sending shares of ...

UnitedHealth Group CEO Andrew Witty stepped down from his executive role in May 2025. The company announced his successor that month in a press release and cited the reason for Witty’s departure.